Research Topics
| Julio MontanerSummaryAffiliation: British Columbia Country: Canada Publications
| Collaborators
|
Detail Information
Publications
Difficulty accessing crack pipes and crack pipe sharing among people who use drugs in Vancouver, CanadaLianping Ti
Faculty of Health Sciences, Simon Fraser University, 8888 University Drive, Burnaby, BC V5A 1S6, Canada
Subst Abuse Treat Prev Policy 6:34. 2011..Therefore, we sought to identify the prevalence and correlates of crack pipe sharing among a community-recruited sample of people who use illicit drugs in Vancouver, a setting where crack pipes are provided at low or no cost...
Impact of a medically supervised safer injecting facility on drug dealing and other drug-related crimeEvan Wood
British Columbia Centre for Excellence in HIV AIDS, St, Paul s Hospital, 608 1081 Burrard Street, Vancouver BC V6Z 1Y6, Canada
Subst Abuse Treat Prev Policy 1:13. 2006..116) or assaults/robbery (174 vs. 180), although a decline in vehicle break-ins/vehicle theft was observed (302 vs. 227). The SIF was not associated with increased drug trafficking or crimes commonly linked to drug use...
Hunger and associated harms among injection drug users in an urban Canadian settingAranka Anema
British Columbia Centre for Excellence in HIV AIDS, St, Paul s Hospital, Vancouver, BC, Canada
Subst Abuse Treat Prev Policy 5:20. 2010..Food insufficiency is often associated with health risks and adverse outcomes among marginalized populations. However, little is known about correlates of food insufficiency among injection drug users (IDU)...
HIV/AIDS in Vancouver, British Columbia: a growing epidemicColin W McInnes
British Columbia Centre for Excellence in HIV AIDS, St, Paul s Hospital, 608 1081 Burrard Street, Vancouver, British Columbia, V6Z 1Y6, Canada
Harm Reduct J 6:5. 2009..These results suggest that HIV infection is having a relatively large impact in Vancouver and that evidence-based prevention and harm reduction strategies should be expanded...
Asking the right questions: developing evidence-based strategies for treating HIV in women and childrenQuarraisha Abdool Karim
Department of Epidemiology, Columbia University, New York, USA
BMC Public Health 11:388. 2011..The guideline's new goals present an opportunity for advancing the women and children's agenda outlined in the Consensus Statement...
Injection drug use among street-involved youth in a Canadian settingThomas Kerr
British Columbia Centre for Excellence in HIV AIDS, St, Paul s Hospital, British Columbia, Canada
BMC Public Health 9:171. 2009..We undertook this study to examine the prevalence of injection drug use and associated risks among street-involved youth in Vancouver, Canada...
Structural factors associated with an increased risk of HIV and sexually transmitted infection transmission among street-involved youthBrandon D L Marshall
British Columbia Centre for Excellence in HIV AIDS, St, Paul s Hospital, 608 1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada
BMC Public Health 9:7. 2009....
Elevated HIV risk behaviour among recently incarcerated injection drug users in a Canadian setting: a longitudinal analysisM J S Milloy
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, Canada
BMC Public Health 9:156. 2009..We sought to assess the impact of incarceration on risk factors for HIV infection after release from prison in a sample of active IDU in Vancouver, Canada...
Physician's manual reporting underestimates mortality: evidence from a population-based HIV/AIDS treatment programChristopher G Au-Yeung
British Columbia Centre for Excellence in HIV AIDS, Vancouver, British Columbia, Canada
BMC Public Health 10:642. 2010..We examined the rate of underreporting of deaths by manual methods as compared with electronic reports from a vital event registry...
Determinants of hospitalization for a cutaneous injection-related infection among injection drug users: a cohort studyElisa Lloyd-Smith
British Columbia Centre for Excellence in HIV AIDS, Providence Health Care, 608 1081 Burrard Street, Vancouver, V6Z 1Y6, Canada
BMC Public Health 10:327. 2010..The objective of this study was to investigate determinants of hospitalization for a CIRI or related infectious complication among a cohort of supervised injection facility (SIF) users...
Unstable housing and hepatitis C incidence among injection drug users in a Canadian settingChristina Kim
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, Canada
BMC Public Health 9:270. 2009....
Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort studyElisa Lloyd-Smith
BC Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, BC, Canada
BMC Public Health 8:405. 2008..However, risk factors for CIRI have not been well described in the literature. We sought to characterize the risk factors for current CIRI among individuals who use North America's first supervised injection facility (SIF)...
Pathways to HIV risk and vulnerability among lesbian, gay, bisexual, and transgendered methamphetamine users: a multi-cohort gender-based analysisBrandon D L Marshall
British Columbia Centre for Excellence in HIV AIDS, St, Paul s Hospital, 608 1081 Burrard Street, Vancouver, BC, Canada
BMC Public Health 11:20. 2011..We sought to assess potential relationships between MA use and individual, social, and structural HIV vulnerabilities among sexual minority (lesbian, gay, bisexual or transgendered) drug users...
High lifetime pregnancy and low contraceptive usage among sex workers who use drugs- an unmet reproductive health needPutu Duff
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, 608 1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada
BMC Pregnancy Childbirth 11:61. 2011..The objective of this study was to describe levels of pregnancy and contraceptive usage among a cohort of street-based female sex workers (FSWs) in Vancouver...
Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countriesJanet M Raboud
Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
BMC Infect Dis 10:40. 2010....
Estimating the impact of expanded access to antiretroviral therapy on maternal, paternal and double orphans in sub-Saharan Africa, 2009-2020Aranka Anema
British Columbia Centre for Excellence in HIV AIDS, St, Paul s Hospital, Vancouver, British Columbia, Canada
AIDS Res Ther 8:13. 2011..abstract:..
Expanded highly active antiretroviral therapy coverage among HIV-positive drug users to improve individual and public health outcomesJulio S G Montaner
BC Centre for Excellence in HIV AIDS, Providence Health Care, Vancouver, British Columbia, Canada
J Acquir Immune Defic Syndr 55:S5-9. 2010....
Prognostic staging of extensively pretreated patients with advanced HIV-1 diseaseJulio Montaner
St Paul s Hospital, University of British Columbia, Vancouver, Canada
HIV Clin Trials 6:281-90. 2005..Positive prognostic factors (PPFs) in the TORO trials could serve as the basis for a prognostically meaningful staging of treatment-experienced patients initiating a new antiretroviral regimen...
The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemicJulio S G Montaner
British Columbia Centre for Excellence in HIV/AIDS, Providence Health Care, University of British Columbia, Vancouver, Canada
Lancet 368:531-6. 2006
Efficacy, safety and pharmacokinetics of once-daily saquinavir soft-gelatin capsule/ritonavir in antiretroviral-naive, HIV-infected patientsJulio S G Montaner
St Paul s Hospital, University of British Columbia, Vancouver, BC, Canada
MedGenMed 8:36. 2006..Once-daily HIV treatment regimens are being used in clinical practice with the objective of improving patient acceptance and adherence...
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based studyJulio S G Montaner
British Columbia Centre for Excellence in HIV AIDS, Providence Health Care, Vancouver, BC, Canada
Lancet 376:532-9. 2010..We aimed to estimate the association between plasma HIV-1 viral load, HAART coverage, and number of new cases of HIV in the population of a Canadian province...
Incarceration experiences in a cohort of active injection drug usersM J Milloy
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, Canada
Drug Alcohol Rev 27:693-9. 2008..Incarceration has been associated with a number of health-related harms among injection drug users (IDU). However, little is known about the prevalence and correlates of incarceration among community-based samples of IDU...
Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugsKora deBeck
British Columbia Centre for Excellence in HIV AIDS, University of British Columbia, Vancouver, BC
CMAJ 181:585-9. 2009..Given the increasing use of crack cocaine, we sought to examine whether use of this illicit drug has become a risk factor for HIV infection...
Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringesThomas Kerr
British Columbia Centre for Excellence in HIV AIDS, Department of Medicine, University of British Columbia, Vancouver, Canada
Am J Public Health 100:1449-53. 2010..We assessed the effects of syringe exchange program (SEP) policy on rates of HIV risk behavior and HIV incidence among injection drug users...
Changes in injecting practices associated with the use of a medically supervised safer injection facilityJo Anne Stoltz
Clinical Activities, British Columbia Centre of Excellence in HIV AIDS, University of British Columbia, Vancouver, Canada
J Public Health (Oxf) 29:35-9. 2007....
HIV risks associated with incarceration among injection drug users: implications for prison-based public health strategiesDaniel Werb
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, 608 1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada
J Public Health (Oxf) 30:126-32. 2008..We sought to evaluate the potential impact of incarceration on HIV risk behaviour among the IDU enrolled in a prospective cohort study...
Social and environmental predictors of plasma HIV RNA rebound among injection drug users treated with antiretroviral therapyM J Milloy
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, Canada
J Acquir Immune Defic Syndr 59:393-9. 2012..Although studies have suggested higher rates of plasma viral load (PVL) rebound among IDU on antiretroviral therapy (ART), risk factors for rebound have not been thoroughly investigated...
Risks surrounding drug trade involvement among street-involved youthDaniel Werb
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, British Columbia, Canada
Am J Drug Alcohol Abuse 34:810-20. 2008..The present study was therefore conducted to investigate factors associated with the street-level drug trade involvement among street-based youth...
Incarceration and drug use patterns among a cohort of injection drug usersKora deBeck
British Columbia Centre for Excellence in HIV AIDS, Vancouver, BC, Canada
Addiction 104:69-76. 2009..However, the impact of incarceration on deterring drug use remains under-evaluated. We sought to explore the relationship between incarceration and patterns of drug use among people who inject drugs (IDU)...
Effect of methadone treatment on incarceration rates among injection drug usersDaniel Werb
British Columbia Centre for Excellence in HIV AIDS, St Pauls Hospital, Vancouver, B C, Canada
Eur Addict Res 14:143-9. 2008..However, questions remain concerning the effect of MMT in reducing rates of incarceration among IDU. We therefore sought to investigate the long-term effect of MMT on rates of incarceration...
Ongoing drug use and outcomes from highly active antiretroviral therapy among injection drug users in a Canadian settingAndrea Krusi
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, BC, Canada
Antivir Ther 15:789-96. 2010..We sought to investigate the influence of drug use patterns on adherence to antiretroviral therapy and virological suppression among IDUs...
Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settingsRichard Bedell
Centre for Excellence in HIV/AIDS, University of British Columbia, Vancouver, British Columbia, Canada
Antivir Ther 8:379-84. 2003..Our results suggest that, if appropriately validated, judicious application of total lymphocyte counts could overcome one of the practical obstacles to more widespread provision of antiretroviral therapy in resource-poor settings...
Police and public health partnerships: evidence from the evaluation of Vancouver's supervised injection facilityKora deBeck
British Columbia Centre for Excellence in HIV AIDS, 608 1081 Burrard Street, Vancouver, B, C, V6Z 1Y6, Canada
Subst Abuse Treat Prev Policy 3:11. 2008..Our study suggests that the SIF provides an opportunity to coordinate policing and public health efforts and thereby resolve some of the existing tensions between public order and health initiatives...
Effects of police confiscation of illicit drugs and syringes among injection drug users in VancouverDaniel Werb
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, Canada
Int J Drug Policy 19:332-8. 2008..Drug market policing has been associated with various harms among injection drug users (IDU). However, little is known about instances in which drugs and injecting equipment are confiscated from IDU in the absence of a formal arrest...
Prevalence and clinical implications of insertions in the HIV-1 p6Gag N-terminal region in drug-naive individuals initiating antiretroviral therapyZabrina L Brumme
BC Centre for Excellence in HIV/AIDS, St Paul's Hospital, Vancouver, British Columbia, Canada
Antivir Ther 8:91-6. 2003..1). The data suggest that HIV p6Gag insertions are not exclusively related to drug resistance and may not influence response to antiretroviral therapy, but may be linked to sequence variations in the HIV envelope...
Interest in low-threshold employment among people who inject illicit drugs: implications for street disorderKora deBeck
BC Centre for Excellence in HIV AIDS, 608 1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6
Int J Drug Policy 22:376-84. 2011..Among a cohort of injection drug users (IDU) we sought to examine street-based income generation practices and willingness to forgo these sources of income if other low-threshold work opportunities were made available...
Public crack cocaine smoking and willingness to use a supervised inhalation facility: implications for street disorderKora deBeck
British Columbia Centre for Excellence in HIV AIDS, Vancouver, Canada
Subst Abuse Treat Prev Policy 6:4. 2011....
The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: a qualitative studyWill Small
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, BC, Canada
AIDS Care 21:708-14. 2009..We sought to qualitatively evaluate experiences with HAART among HIV-positive IDU who had been recently incarcerated within provincial prisons in British Columbia in order to identify factors influencing adherence to treatment...
A dose-dependent relationship between exposure to a street-based drug scene and health-related harms among people who use injection drugsKora deBeck
British Columbia Centre for Excellence in HIV AIDS, 608 1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada
J Urban Health 88:724-35. 2011..These findings highlight opportunities for policy interventions to address exposure to street disorder in the areas of employment, housing, and addiction treatment...
Validity of self-reported adherence among injection drug usersThomas Kerr
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
J Int Assoc Physicians AIDS Care (Chic) 7:157-9. 2008....
Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug usersThomas Kerr
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, 608 1081 Burrard Street, Vancouver, BC, Canada
Drug Alcohol Depend 87:39-45. 2007..Non-fatal overdose is a major determinant of morbidity among injection drug users (IDU). We sought to evaluate factors associated with non-fatal overdose among IDU in Vancouver...
Crystal methamphetamine use associated with non-fatal overdose among a cohort of injection drug users in VancouverNadia Fairbairn
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, 608 1081 Burrard Street, Vancouver, BC Canada, V6Z 146
Public Health 122:70-8. 2008..To evaluate the prevalence and correlates of non-fatal overdose among a polysubstance-using cohort of injection drug users (IDU) in Vancouver...
Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapyMagdalena A Recsky
British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, British Columbia, Canada
J Infect Dis 190:285-92. 2004..001). CONCLUSION: Only a relatively low prevalence of multidrug resistance was observed in this cohort, indicating that the exhaustion of treatment options because of drug resistance was not a significant contributor to mortality...
Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapyAnita Palepu
Centre for Health Evaluation and Outcome Sciences, St Paul s Hospital, University of British Columbia, BC, Canada
Drug Alcohol Depend 84:188-94. 2006..We examined the association of methadone maintenance therapy (MMT) with highly active antiretroviral therapy (HAART) adherence and HIV treatment outcomes among a cohort of HIV/HCV co-infected injection drug users (IDUs)...
Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapyP Richard Harrigan
British Columbia Centre for Excellence in HIV AIDS, and Department of Medicine, University of British Columbia, Vancouver, Canada
J Infect Dis 191:339-47. 2005....
Homelessness as a structural barrier to effective antiretroviral therapy among HIV-seropositive illicit drug users in a Canadian settingM J Milloy
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, British Columbia
AIDS Patient Care STDS 26:60-7. 2012..However, since this relationship appears to be mediated by lower levels of ART adherence, interventions to improve adherence among members of this vulnerable population are needed...
Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcareChristine Tapp
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, and Department of Medicine, University of British Columbia, Vancouver, Canada
BMC Infect Dis 11:86. 2011..We evaluated access and adherence to ART in a long-term cohort of HIV-positive IDU in a setting where medical care and antiretroviral therapy are provided free of charge through a universal healthcare system...
Effect of drug law enforcement on drug market violence: a systematic reviewDan Werb
British Columbia Centre for Excellence in HIV AIDS, Vancouver, Canada
Int J Drug Policy 22:87-94. 2011..In this context, and since drug prohibition has not meaningfully reduced drug supply, alternative regulatory models will be required if drug supply and drug market violence are to be meaningfully reduced...
Inability to access addiction treatment and risk of HIV infection among injection drug users recruited from a supervised injection facilityM J S Milloy
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, BC, Canada
J Public Health (Oxf) 32:342-9. 2010..We sought to examine the prevalence and correlates of being unable to access addiction treatment in a representative sample of injection drug users randomly recruited from a supervised injection facility...
Nonfatal overdose among a cohort of street-involved youthDaniel Werb
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, Canada
J Adolesc Health 42:303-6. 2008..Our findings indicate that nonfatal overdose was common among street-involved youth in our setting, and was associated with various forms of drug use, including methamphetamine use...
Crystal methamphetamine use among female street-based sex workers: Moving beyond individual-focused interventionsKate Shannon
British Columbia Centre for Excellence in HIV AIDS, Department of Medicine, University of British Columbia, Vancouver, BC, Canada
Drug Alcohol Depend 113:76-81. 2011..The findings highlight the crucial need to move beyond the individual to gender-focused safer environment interventions that mediate the physical and social risk environment of crystal methamphetamine use among FSWs...
Incidence and determinants of initiation into cocaine injection and correlates of frequent cocaine injectorsElisa Lloyd-Smith
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital 608 1081, Burrard Street, Vancouver, BC, V6Z 1Y6, Canada
Drug Alcohol Depend 99:176-82. 2009..To investigate the incidence and correlates of cocaine injection initiation and the impacts of daily cocaine injection among a cohort of injection drug users...
Prevalence and correlates of jugular injections among injection drug usersZia Hoda
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, BC, Canada
Drug Alcohol Rev 27:442-6. 2008..We evaluated factors associated with jugular injection among a cohort of injection drug users (IDU) in Vancouver, Canada...
Methamphetamine use and rates of incarceration among street-involved youth in a Canadian setting: a cross-sectional analysisM J Milloy
BC Centre for Excellence in HIV AIDS, St Paul s Hospital, 608 1081 Burrard Street, Vancouver, BC V6Z 1Y6, Canada
Subst Abuse Treat Prev Policy 4:17. 2009....
Employment among users of a medically supervised safer injection facilityLindsey Richardson
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, British Columbia, Canada
Am J Drug Alcohol Abuse 34:519-25. 2008..05, 95% CI: 0.88-1.27). These findings suggest that the SIF is not having an adverse impact on efforts to seek employment...
Barriers and facilitators to methadone maintenance therapy use among illicit opiate injection drug users in VancouverCody Callon
British Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, British Columbia, Canada
J Opioid Manag 2:35-41. 2006..These findings indicate the need for additional interventions aimed at maximizing coverage of MMT and other treatments for opiate-addicted individuals...
Prevalence and correlates of cervical cancer screening among injection drug usersBruce McKnight
British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Department of Medicine, University of British Columbia, Vancouver, BC, Canada
J Obstet Gynaecol Can 28:695-9. 2006..This is reassuring, given the elevated risk of cervical cancer among this population. Interventions may be required to improve uptake of screening among older injection drug users and drug users infected with hepatitis C...
Injection drug use cessation and use of North America's first medically supervised safer injecting facilityKora deBeck
BC Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, Canada
Drug Alcohol Depend 113:172-6. 2011..There has been concern that the program may facilitate ongoing drug use and delay entry into addiction treatment...
Modelling crack cocaine use trends over 10 years in a Canadian settingDan Werb
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, Canada
Drug Alcohol Rev 29:271-7. 2010..We investigated longitudinal patterns of crack cocaine use among polydrug users in Vancouver, Canada...
Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-upPeter Phillips
Division of Infectious Diseases, St Paul s Hospital, Vancouver, British Columbia, Canada
Clin Infect Dis 41:1483-97. 2005..The long-term outcome and spectrum of disease of nontuberculous mycobacterial immune reconstitution syndrome have not been described...
Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug usersM J Milloy
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, Canada
J Infect Dis 203:1215-21. 2011..Although some studies have identified impressive clinical gains for incarcerated HIV-seropositive injection drug users (IDUs) undergoing antiretroviral therapy (ART), the effect of incarceration on adherence to ART remains undetermined...
Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detectionVikram S Gill
BC Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, British Columbia, Canada
Clin Infect Dis 50:98-105. 2010....
Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemicViviane D Lima
British Columbia Centre for Excellence in HIV AIDS, British Columbia, Canada
J Infect Dis 198:59-67. 2008..These results provide powerful additional motivation to accelerate the roll out of HAART programs aggressively targeting those in medical need, both for their own benefit and as a means of decreasing new HIV infections...
Clinical and immunological impact of HIV envelope V3 sequence variation after starting initial triple antiretroviral therapyZabrina L Brumme
BC Centre for Excellence in HIV/AIDS, St. Paul's Hospital, The Faculty of Medicine, University of British Columbia, 603-1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6
AIDS 18:F1-9. 2004..These results may prove to be useful for the clinical management of HIV-infected individuals...
Management of HIV-infected patients with multidrug-resistant virusMarianne Harris
British Columbia Centre for Excellence in HIV/AIDS, Providence Health Care/University of British Columbia, 667-1081 Burrard Street, Vancouver, BC V6Z 1Y6, Canada
Curr HIV/AIDS Rep 1:116-21. 2004..Some new drugs are available that may be helpful if used carefully with an active background regimen...
Higher baseline levels of plasma human immunodeficiency virus type 1 RNA are associated with increased mortality after initiation of triple-drug antiretroviral therapyEvan Wood
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, and Department of Health Care and Epidemiology, University of British Columbia, Vancouver, Canada
J Infect Dis 188:1421-5. 2003..71; 95% confidence interval, 1.08-2.70; P=.023). If appropriately confirmed, these findings have important implications for the development of therapeutic guidelines...
Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapyEvan Wood
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
J Infect Dis 188:1164-70. 2003..5%) received antiretroviral medication >or=75% of the time during their first year receiving therapy. The data demonstrate the need for novel interventions to expand HIV care to specific populations...
Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microlEvan Wood
British Columbia Centre for Excellence in HIV/AIDS, St Paul's Hospital, 667-1081 Burrard Street, Vancouver, BC, Canada
AIDS 20:1117-23. 2006..89-1.65; P = 0.232). CONCLUSION: HIV RNA > or = 100 000 copies/ml was only associated with mortality among HIV-infected patients initiating HAART with CD4 cell counts > or= 200 cells/microl if the patients were non-adherent...
Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-upRobert S Hogg
Division of Epidemiology and Population Health, BC Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver, British Columbia V6Z 1Y6, Canada
AIDS 16:1051-8. 2002..97 times (95% CI, 1.33-6.62; P = 0.008) more likely to die. CONCLUSION: Our study demonstrates that even after adjusting for other prognostic factors intermittent use of antiretroviral therapy was associated with increased mortality...
Street-level policing in the Downtown Eastside of Vancouver, Canada, during the 2010 Winter OlympicsWill Small
British Columbia Centre for Excellence in HIV AIDS, Canada
Int J Drug Policy 23:128-33. 2012..We examined street-level policing in the Downtown Eastside (DTES) of Vancouver during the Olympic Winter games, to assess the potential impact on access to harm reduction services and injection-related risk behaviour...
Crystal methamphetamine injection predicts slower HIV RNA suppression among injection drug usersNadia Fairbairn
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, University of British Columbia, Vancouver, Canada
Addict Behav 36:762-3. 2011..63 [95% CI: 0.40-0.98]; p=0.039). This study is the first to our knowledge to demonstrate an association between crystal methamphetamine use and HIV RNA suppression...
Social and structural determinants of HAART access and adherence among injection drug usersAndrea Krusi
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, BC V6Z 1Y6, Canada
Int J Drug Policy 21:4-9. 2010....
Violence among street-involved youth: the role of methamphetamineIan Martin
Department of Family Practice, University of British Columbia, Vancouver, BC, Canada
Eur Addict Res 15:32-8. 2009..This study investigated a possible association between violence and the use of drugs, particularly methamphetamine and alcohol...
Use of North America's first medically supervised safer injecting facility among HIV-positive injection drug usersHudson Reddon
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, Canada
AIDS Educ Prev 23:412-22. 2011..The SIF appears to have attracted a high-risk subpopulation of HIV-positive IDUs; this coverage perhaps could be extended with the addition of HIV-specific services such as disease monitoring and the provision of antiretroviral therapy...
Migration adversely affects antiretroviral adherence in a population-based cohort of HIV/AIDS patientsViviane Lima
HIV AIDS Drug Treatment Program, British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, 608 1081 Burrard Street, Vancouver, British Columbia, Canada V6Z 1Y6
Soc Sci Med 68:1044-9. 2009..These results suggest that proactive strategies are needed to ensure that antiretroviral therapy remains available on a continued basis to highly migrant populations...
Impact of a medically supervised safer injection facility on community drug use patterns: a before and after studyThomas Kerr
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, 608 1081 Burrard Street, Vancouver, BC V6Z 1Y6, Canada
BMJ 332:220-2. 2006..Supervised injecting facilities have been proposed as a potential solution, but fears have been raised that they might encourage drug use...
Safer injection facility use and syringe sharing in injection drug usersThomas Kerr
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, 608 1081 Burrard Street, Vancouver, BC V6Z 1Y6, Canada
Lancet 366:316-8. 2005..30, 0.11-0.82, p=0.02) after adjustment for relevant sociodemographic and drug-use characteristics. These findings could help inform discussions about the merits of such facilities...
Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy?Evan Wood
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, Canada
AIDS 17:711-20. 2003..We evaluated whether non-immune-based factors such as physician experience and adherence could affect survival among HIV-infected adults starting HAART...
Intentional nonadherence due to adverse symptoms associated with antiretroviral therapyKatherine V Heath
Centre for Excellence in HIV AIDS, Vancouver, British Columbia, Canada
J Acquir Immune Defic Syndr 31:211-7. 2002..To estimate the frequency and possible predictors of patient-mediated intentional alterations in antiretroviral medication regimens in direct response to symptoms associated with antiretroviral therapy use...
"Discordant" increases in CD4 cell count relative to plasma viral load in a closely followed cohort of patients initiating antiretroviral therapyEvan Wood
British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, Canada
J Acquir Immune Defic Syndr 30:159-66. 2002..Similarities between transient and full virologic responders also appear to be time limited and are often associated with greater cumulative use of antiretroviral therapy by transient virologic responders...
Modest decreases in NNRTI susceptibility do not influence virological outcome in patients receiving initial NNRTI-containing triple therapyP Richard Harrigan
BC Centre for Excellence in HIV AIDS, Vancouver, BC, Canada
Antivir Ther 8:395-402. 2003....
Provider bias in the selection of non-nucleoside reverse transcriptase inhibitor and protease inhibitor-based highly active antiretroviral therapy and HIV treatment outcomes in observational studiesEvan Wood
BC Centre for Excellence in HIV/AIDS, St Paul's Hospital, Vancouver, Canada
AIDS 17:2629-34. 2003..As such, it is likely that similar selection factors may explain why our findings contrast with several non-randomized studies showing worse clinical outcomes of patients prescribed nevirapine...
The impact of adherence on CD4 cell count responses among HIV-infected patientsEvan Wood
British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, BC, Canada
J Acquir Immune Defic Syndr 35:261-8. 2004..85, 95% CI: 3.15-7.47). CONCLUSIONS: These data demonstrate that substantial CD4 gains are possible among highly advanced adherent patients and should contribute to the ongoing debate over the optimal time to initiate HAART...
Does ratification of human-rights treaties have effects on population health?Alexis Palmer
Faculty of Health Sciences, Simon Fraser University, Vancouver, BC, Canada
Lancet 373:1987-92. 2009....
Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohortPaula Braitstein
British Columbia Center for Excellence in HIV AIDS, University of British Columbia, Vancouver, Canada
AIDS 20:323-31. 2006..To characterize the impact of hepatitis C (HCV) serostatus on adherence to antiretroviral treatment (ART) among HIV-infected adults initiating ART...
Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug usersCari L Miller
British Columbia Centre for Excellence in HIV AIDS, University of British Columbia, Vancouver, British Columbia, Canada
Hepatology 36:737-42. 2002..Thus, there is a window of opportunity for prevention. However, the incidence rate of HCV among these young IDUs is alarming, suggesting that the opportunity to intervene is exceedingly small...
Effects of human leukocyte antigen class I genetic parameters on clinical outcomes and survival after initiation of highly active antiretroviral therapyZabrina L Brumme
British Columbia Centre for Excellence in HIV AIDS, Vancouver, BC, Canada
J Infect Dis 195:1694-704. 2007....
Gender differences in HIV-1 RNA rebound attributed to incomplete antiretroviral adherence among HIV-Infected patients in a population-based cohortLaura M Kuyper
British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, British Columbia, Canada
J Acquir Immune Defic Syndr 37:1470-6. 2004....
Physician experience and rates of plasma HIV-1 RNA suppression among illicit drug users: an observational studySassan Sangsari
Department of Integrated Sciences, University of British Columbia, Vancouver, BC, Canada
BMC Infect Dis 12:22. 2012..As there is an urgent need to improve responses to antiretroviral therapy among this population, we undertook this study to evaluate the role of physician experience on rates of plasma HIV-1 RNA suppression following initiation of ART...
The validity of reporting willingness to use a supervised injecting facility on subsequent program use among people who use injection drugsKora deBeck
British Columbia Centre for Excellence in HIV AIDS, Vancouver, Canada
Am J Drug Alcohol Abuse 38:55-62. 2012..The validity of these surveys has not been fully evaluated. We sought to determine whether measures of willingness collected prior to the opening of a Canadian SIF accurately predicted subsequent use of the program...
Methadone use among HIV-positive injection drug users in a Canadian settingTyler Pettes
British Columbia Centre for Excellence in HIV AIDS, Vancouver, BC, Canada
J Subst Abuse Treat 39:174-9. 2010..49, 95%CI = 1.81-11.13) was positively associated with subsequent discontinuation of MMT. These findings demonstrate the benefits of MMT among HIV-positive IDU and the need to improve access to and retention in MMT...
Estimated drug overdose deaths averted by North America's first medically-supervised safer injection facilityM J S Milloy
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, Vancouver, Canada
PLoS ONE 3:e3351. 2008..We sought to estimate the number of deaths potentially averted by the implementation of a medically supervised safer injection facility (SIF) in Vancouver, Canada...
Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug useAnita Palepu
Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada
J Acquir Immune Defic Syndr 32:522-6. 2003..07, 95% CI: 0.87-1.33). Current injection drug users were less likely to achieve HIV-1 RNA suppression compared with non-drug users. Adherence as measured by pharmacy refill compliance was not a reliable measure in this subpopulation...
Factors associated with buying and selling syringes among injection drug users in a setting of one of North America's largest syringe exchange programsLaura M Kuyper
British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, and Department of Health Care and Epidemiology, University of British Columbia, Vancouver, Canada
Subst Use Misuse 41:883-99. 2006..Syringe buyers were more likely to need help injecting, have difficulty finding new syringes, have binged on drugs, and have visited the SEP at least once weekly. Syringe buying most frequently occurred when the SEP was closed...
Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV/AIDS treatment programPaula Braitstein
British Columbia Centre for Excellence in HIV AIDS, University of British Columbia, Vancouver, Canada
J Infect Dis 193:259-68. 2006..We sought to characterize the impact that hepatitis C virus (HCV) infection has on CD4 cells during the first 48 weeks of antiretroviral therapy (ART) in previously ART-naive human immunodeficiency virus (HIV)-infected patients...
Complementary and alternative medicine use in British Columbia--a survey of HIV positive people on antiretroviral therapyShayesta Dhalla
Department of Health Care and Epidemiology, University of British Columbia, Vancouver, British Columbia, Canada
Complement Ther Clin Pract 12:242-8. 2006..45). CAM use is common. Both patients and health professionals should be aware of potential toxicities and drug interactions related to the use of CAM and HIV/AIDS treatment...
The future face of coinfection: prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug usersCari L Miller
British Columbia Centre for Excellence in HIV AIDS, Vancouver, and Department of Health Care and Epidemiology, University of British Columbia, Vancouver, Canada
J Acquir Immune Defic Syndr 36:743-9. 2004..The median number of years injecting for youth seroconverting to a secondary infection was 3 years, suggesting that appropriate public health interventions should be implemented immediately...
Rates of disease progression among human immunodeficiency virus-infected persons initiating multiple-drug rescue therapyNelson Lee
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada
J Infect Dis 188:137-41. 2003..Over the short-term, patients receiving MDRT had relatively low mortality. After adjustment for baseline prognostic factors, rates of survival were comparable with those in patients initiating triple-drug ART...
Increased resilience to the development of drug resistance with modern boosted protease inhibitor-based highly active antiretroviral therapyViviane D Lima
British Columbia Centre for Excellence in HIV AIDS, St Paul s Hospital, British Columbia, Canada
J Infect Dis 198:51-8. 2008..We explore the temporal and regimen-specific changes of HIV-1 drug resistance in a large cohort of antiretroviral-naive individuals starting highly active antiretroviral therapy (HAART)...
Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapyAnita Palepu
All the authors are with the University of British Columbia, British Columbia, Canada
J Urban Health 80:667-75. 2003..As well, increased outreach to HIV-infected drug users recently released from prison to ensure continuity of care needs to be further developed...
Lopinavir/ritonavir pharmacokinetics in a substitution of high-dose soft-gelatin capsule to tablet formulationMark W Hull
Canadian HIV Trials Network, Vancouver, Canada
J Clin Pharmacol 49:155-61. 2009....
